Scientists: the Vaccine in a month's time, but to get on the market, it takes more

Viruses of Wuhan is in the vaccine, however, scientists say, will not be ready before a month. And in China, the isolated cities become ten. The health authorities of Shanghai, meanwhile, have raised the level of response to health emergencies to the maximum level, level 1. It refers in a tweet to the Shanghai Daily. In the metropolis at the delta of the yangtze River, Shanghai Disneyland has announced the closing of the facility starting tomorrow. And meanwhile, two new cases of pneumonia caused by coronavirus have been confirmed in Singapore, where now there are three people infected. This was confirmed by the Ministry of Health of the city-State in asia.

A patient is a man of 37 years, son of the first patient on whom it was verified the presence of the coronavirus, while the second is a woman of 53 years came to Singapore from Wuhan on the 21st of last January, aboard a flight of the airlines of low-cost Scoot, yesterday announced the suspension of flights to and from the chinese city, from which it spread to pneumonia caused by coronavirus.
a total of 44 suspected cases recorded in Singapore, and relate to people from 1 to 78 years old: thirteen of them are negative results in the early medical tests.

Indented instead of yesterday evening, the suspect case in Bari: the woman had a similar pathology, but it was not the virus of Wuhan. But then to place it on the market, it can take much more. Scientists at the University of Texas Medical Branch (Utmb) Galveston, in the Usa, are monitoring the spread of the new virus and the chinese are already working on a vaccine. "We have a lot of experience: we have worked on Sars, Ebola, the Mers (Middle East Respiratory Syndrome)," he said in an interview with professor Thomas Ksiazek of Utmb where he directs the High Containment Laboratory Operations. The genetic sequence of the virus of Wuhan has been published on the site GeneBank, accessible to all researchers. "The material on which work is emerging now. We are in the initial phase. You can start with the scenes, but to find a vaccine, it is preferable to have the virus authentic in the laboratory," he explained Ksiazek, virologist among the leading experts in the Ebola.